Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression-Reference-Cited by-同舟云学术

Understanding Treatment Response in Individual Profiles of Men with Prostatic Enlargement at Risk of Progression

Published:2023-01 Issue:1 Volume:9 Page:178-187
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Gravas Stavros,Palacios-Moreno Juan Manuel,Thompson Douglas,Concas Federico,Kamola Piotr J.,Roehrborn Claus G.,Oelke Matthias,Kattan Michael W.,Averbeck Marcio Augusto,Manyak Michael,Cortés Vanessa,Lulic Zrinka

Funder

Astellas Pharma US

GlaxoSmithKline

Pfizer

GlaxoSmithKline España

Publisher

Elsevier BV

Subject

Urology

Reference25 articles.

1. Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base;Gacci;Ther Adv Urol,2017

2. Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain;Miñana;Int J Clin Pract,2021

3. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction;Oelke;Eur Urol,2013

4. Gravas S, Cornu JN, Gacci M, et al. EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), including benign prostatic obstruction (BPO). Arnhem, The Netherlands: European Association of Urology; 2022. https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts.

5. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling study of the effect of placebo and medical therapy on storage and voiding symptoms, nocturia, and quality of life in men with prostate enlargement at risk for progression;Prostate Cancer and Prostatic Diseases;2023-10-04

2. Unveiling prostatic inflammation to optimize management of lower urinary tract symptoms: a discussion with experts;Biomarkers in Medicine;2023-09

3. When is the best surgical time for benign prostate hyperplasia treatment?;Asian Journal of Andrology;2023-08-15

4. Treating LUTS in Men with Benign Prostatic Obstruction: A Review Article;Drugs & Aging;2023-08-09

5. What is new in the pharmacotherapy of benign prostatic hyperplasia;Klinická farmakologie a farmacie;2023-04-21